Published on 11 Apr 2024 on Simply Wall St. via Yahoo Finance
X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) market cap decline of US$42m may not have as much of an...
Key Insights
Institutions' substantial holdings in X4 Pharmaceuticals implies that they have significant influence over the company's share price51% of the business is held by the top 11 shareholdersOwnership research along with analyst forecasts data help provide a good understanding of opportunities in a stock
If you want to know who really controls X4 Pharmaceuticals, Inc. (NASDAQ:XFOR), then you'll have to look at the makeup of its share registry. We can see that institutions own the lion's share in the company with 49% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).